James Richardson
Internal Medicine · Ontario, OHNPI 1770524001
Payments from drug & device makers
Across 126 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$274
- Takeda Pharmaceuticals U.S.A., Inc.$167
- Amgen$153
- Johnson & Johnson$126
- Biohaven Pharmaceuticals, Inc.$121
- Biohaven Pharmaceutical Holding Company Ltd.$117
- plus $851 from 22 others
What the payments were for
- Food & beverage$1,77698%
- Education$312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 15 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $167 |
| Amgen | 4 | $153 |
| Johnson & Johnson(2 entities) | 8 | $126 |
| Biohaven Pharmaceuticals, Inc. | 20 | $121 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $117 |
| AstraZeneca | 8 | $110 |
| Pfizer | 7 | $88 |
| Novo Nordisk | 6 | $87 |
| Kowa Pharmaceuticals America, Inc. | 5 | $72 |
| GSK | 3 | $51 |
| Astellas Pharma US Inc | 3 | $49 |
| Novartis | 3 | $45 |
| Lilly USA, LLC | 3 | $44 |
| Mylan Specialty L.p. | 3 | $41 |
| Bausch Health US, LLC | 2 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Merck | 2 | $25 |
| AbbVie | 2 | $25 |
| Irhythm Technologies, Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Indivior Inc. | 1 | $18 |
| Orexo US, Inc. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Circassia Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Abbott | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$1,808 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 74 | $9,661 |
| Buprenorphine Hcl | 24 | $739 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Ontario
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
- Yevgeniy BukhmanCanton$3.7M
- Leela VrishabhendraCincinnati$3.4M
- Narinder SainiSpringfield$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.